4 free views remaining today
bullous pemphigoid
ICD-10 Codes
Related ICD-10:
Description
Bullous pemphigoid is an autoimmune disease that causes blisters on the skin, typically affecting older adults. The symptoms may include:
- Itching, which can start weeks or months before blisters form [1]
- Large blisters that don't break easily and rupture forming crusted erosions [4]
The condition is characterized by a chronic autoimmune response, where the body's immune system mistakenly attacks healthy skin tissue, leading to blister formation. Bullous pemphigoid is often associated with severe itch and can involve mucous membranes in some cases [5].
The blisters caused by bullous pemphigoid are typically large, tense, and fluid-filled, and may rupture to form crusted erosions. The condition tends to subside spontaneously in many cases, but treatment with corticosteroids or nonsteroidal medications may be necessary to manage symptoms [9].
Additional Characteristics
- itching that can start weeks or months before blisters form
- large blisters that don't break easily and rupture forming crusted erosions
- chronic autoimmune response where the body's immune system mistakenly attacks healthy skin tissue leading to blister formation
- severe itch
- involvement of mucous membranes in some cases
- blisters are typically large tense and fluid-filled and may rupture to form crusted erosions
Signs and Symptoms
Common Signs and Symptoms of Bullous Pemphigoid
Bullous pemphigoid is a rare skin condition characterized by the presence of itchy, hive-like welts or fluid-filled blisters. The symptoms can vary from person to person, but here are some common signs and symptoms associated with this condition:
- Itching: Itching is often the first symptom of bullous pemphigoid, which can start weeks or months before the blisters form [1].
- Rash: A rash may appear, which can last for days or weeks. The rash can look like hives (or large welts) and can be itchy [2].
- Large blisters: As the condition develops, large blisters can form on the skin. These blisters are usually tense and fluid-filled, and they can rupture to form crusted erosions [5].
- Pruritus: Pruritus is the first symptom of bullous pemphigoid in many cases. Skin lesions may not develop for several years after the onset of pruritus [7].
- Discoloration or abnormal pigmentation: In some cases, bullous pemphigoid can cause discoloration or abnormal pigmentation of the skin [9].
It's essential to note that these symptoms can vary in severity and duration. Bullous pemphigoid is a chronic condition that may last for several years.
References:
[1] - The symptoms of bullous pemphigoid may include: Itching, which can start weeks or months before blisters form. [2] - Rash may appear, which can last for days or weeks. Along with itchy skin, some people develop a rash that can look like hives (or large welts), ... [5] - Bullous pemphigoid causes severe itch and (usually) large, tense bullae (fluid-filled blisters), which rupture forming crusted erosions. [7] - Symptoms and Signs of Bullous Pemphigoid. Pruritus is the first symptom of bullous pemphigoid. Skin lesions may not develop for several years. Often ... [9] - Result: discoloration or abnormal pigmentation of skin
Diagnostic Tests
Diagnostic Tests for Bullous Pemphigoid
Bullous pemphigoid is a chronic autoimmune skin disease characterized by the formation of blisters on the skin. To establish a diagnosis, several diagnostic tests can be performed.
- Histopathologic Analysis: A biopsy from the edge of a blister is essential to confirm the diagnosis of bullous pemphigoid [1]. This test helps in identifying the presence of eosinophils and other inflammatory cells.
- Direct Immunofluorescence (DIF): DIF microscopy of a perilesional biopsy is considered the gold standard for diagnosing bullous pemphigoid [3]. It detects linear deposition of IgG and/or C3 at the dermoepidermal junction, which is a hallmark of this disease.
- Indirect Immunofluorescence (IIF): IIF testing on skin and serum can also be performed to detect antibodies against BP180 and BP230 [4]. This test is useful for monitoring disease activity after a diagnosis has been established.
- Skin Biopsy: A skin biopsy is essential to confirm the diagnosis of bullous pemphigoid. It helps in identifying the presence of eosinophils and other inflammatory cells [5].
- Immunofluorescence Testing: Immunofluorescence testing on skin and serum can be performed to detect antibodies against BP180 and BP230 [4].
References:
[1] Oct 14, 2020 — To establish a diagnosis of bullous pemphigoid, the following tests should be performed: histopathologic analysis from the edge of a blister and ...
[3] by E Schmidt · 2009 · Cited by 9 — Figure 1. Diagnostic pathway in bullous pemphigoid (BP). Figure 1. ... Direct immunofluorescence (IF) microscopy of a perilesional biopsy is the gold standard for ...
[4] Dec 7, 2023 — ELISAs to detect antibodies against BP180 and BP230 may be appropriate for monitoring disease activity after a diagnosis of pemphigoid with ...
[5] Mucous membrane involvement is rare. Diagnosis is by skin biopsy and immunofluorescence testing of skin and serum.
Note: The above information is based on the search results provided in the context.
Additional Diagnostic Tests
- Skin Biopsy
- Histopathologic Analysis
- Direct Immunofluorescence (DIF)
- Indirect Immunofluorescence (IIF)
- Immunofluorescence Testing
Treatment
Bullous pemphigoid is a chronic autoimmune skin disease characterized by blistering and inflammation. The primary goal of drug treatment is to reduce the severity of symptoms, prevent further blistering, and improve quality of life.
First-line treatments:
- Topical corticosteroids are often used as the first-line treatment for bullous pemphigoid [5][8]. These medications help to heal the skin, prevent new blisters from forming, and reduce inflammation.
- Systemic corticosteroids, such as prednisone or prednisolone, may be prescribed in more severe cases or when topical treatments are not effective [9].
Alternative treatments:
- Tetracyclines, including doxycycline, have been found to be effective in treating bullous pemphigoid and may be used as an alternative to corticosteroids [3][7]. Doxycycline has anti-inflammatory effects and can help reduce blistering.
- Niacinamide and tetracycline combination therapy may also be considered for the treatment of autoimmune blistering disorders, such as bullous pemphigoid [6].
Treatment considerations:
- Long-term corticosteroid use may lead to significant side effects, including osteoporosis, cataracts, and glaucoma. Therefore, alternative treatments should be considered when possible.
- The initial dose of steroid tablets for most patients with bullous pemphigoid is 0.5 mg/kg/day, which can be adjusted based on individual response [9].
It's essential to consult a dermatologist or healthcare provider for personalized treatment recommendations and monitoring, as the optimal treatment plan may vary depending on individual factors.
References: [1] - Not applicable (no relevant information in context) [2] - Not applicable (no relevant information in context) [3] Context #3 [4] - Not applicable (no relevant information in context) [5] Context #8 [6] Context #6 [7] Context #7 [8] Context #5 [9] Context #9
Recommended Medications
- Topical corticosteroids
- Systemic corticosteroids (prednisone or prednisolone)
- Tetracyclines (doxycycline)
- Niacinamide and tetracycline combination therapy
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Bullous pemphigoid (BP) is a chronic autoimmune skin disease characterized by the formation of blisters on the skin and mucous membranes. When it comes to differential diagnosis, several conditions need to be considered that can present with similar symptoms.
- Dermatitis herpetiformis: This condition presents with severe, itchy blisters on the skin, often accompanied by a history of celiac disease or gluten sensitivity [1]. While it shares some similarities with BP, dermatitis herpetiformis is typically more itchy and has a different histopathological appearance.
- Cicatricial (scarring) pemphigoid: This condition presents with severe erosive lesions on the mucous membranes, often accompanied by skin involvement in one-third of patients [2]. Like BP, cicatricial pemphigoid is an autoimmune disease that affects the skin and mucous membranes.
- Dermatomyositis: This is a rare inflammatory disease that affects the muscles and skin. It can present with blisters on the skin, but it also has distinct muscle weakness and other systemic symptoms [5].
- Systemic lupus erythematosus (SLE): SLE is an autoimmune disease that can affect multiple organs, including the skin. While it can present with blisters, SLE typically has a more widespread impact on the body, with symptoms such as fever, joint pain, and kidney problems [5].
- Acquired bullous epidermolysis: This condition presents with blistering of the skin due to a defect in the basement membrane zone. It is often associated with autoimmune diseases or genetic disorders [6].
It's essential to note that BP can also be associated with other autoimmune diseases, such as diabetes mellitus, thyroiditis, and systemic lupus erythematosus [5]. A thorough medical history, physical examination, and laboratory tests are necessary to rule out these conditions and establish a definitive diagnosis.
References: [1] - Context result 4 [2] - Context result 3 [5] - Context result 5 [6] - Context result 6
Additional Differential Diagnoses
- Acquired bullous epidermolysis
- dermatomyositis
- cicatricial pemphigoid
- dermatitis herpetiformis
- systemic lupus erythematosus
- co-trimoxazole allergy
- erythema multiforme
- variola major
- junctional epidermolysis bullosa Herlitz type
- pemphigus vulgaris
- miliaria profunda
- epidermolysis bullosa simplex localized type
- chronic urticaria
- chronic inducible urticaria
- chronic spontaneous urticaria
- pemphigus foliaceus
- paraneoplastic pemphigus
- allergic urticaria
- vesiculobullous skin disease
- lichen planus
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:8506
- core#notation
- DOID:8506
- oboInOwl#hasDbXref
- UMLS_CUI:C0030805
- IAO_0000115
- A pemphigoid that is characterized by large blisters.
- rdf-schema#label
- bullous pemphigoid
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0080841
- relatedICD
- http://example.org/icd10/L12.0
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_13234
- owl#annotatedSource
- t451121
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.